PPARA and metabolic dysfunction-associated steatohepatitis: Recent experimental studies strongly suggest that decreased hepatic PPARα expression positively correlates with insulin resistance and NASH severity, while NASH resolution is associated with an upregulation of PPARα as well as its target genes [92].